Cart
sales@molnova.com
[Arg8]-Vasotocin TFA (113-80-4 free base)
CAS No.
[Arg8]-Vasotocin TFA (113-80-4 free base) ( )
Catalog No. M30051 CAS No.
[Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product Name[Arg8]-Vasotocin TFA (113-80-4 free base)
-
NoteResearch use only, not for human use.
-
Brief Description[Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.
-
Description[Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.(In Vitro):[Arg8]-Vasotocin occurs throughout the vertebrate phyla, being present in primitive fish, the cyclostomes, and remaining unchanged in vertebrates up to and including birds. [Arg8]-Vasotocin excites neurones in the dorsal vagal complex in vitro.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight1164.2
-
Molecular FormulaC45H68F3N15O14S2
-
Purity>98% (HPLC)
-
SolubilityH2O : 50 mg/mL (42.95 mM; Need ultrasonic)
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Ingram CD, et al [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors. J Neuroendocrinol. 1994 Aug;6(4):415-22.
molnova catalog
related products
-
Xanthinol Nicotinate
Xanthinol Nicotinate is a potent vasodilator that can easily enter the cell and causes an increase in glucose metabolism resulting in an increased energy.
-
RCGD423
RCGD423 a small molecule gp130 modulator prevents articular cartilage degeneration and promotes repair.
-
Dasatinib N-oxide
Dasatinib N-oxide is a major metabolite of the Abl and Src kinase inhibitor dasatinib.It is also a potential impurity in commercial preparations of dasatinib.
